The trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, ...
The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...
The Kenya Times on MSN15d
Concerns as Hospitals Run Out of BCG VaccinesHospitals across the country are now facing a shortage of the Bacille Calmette-Guérin (BCG) vaccine, which protects newborns ...
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
A new study published in the Journal of Internal Medicine showed that it may be possible to prevent the formation of ...
Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...
H.C. Wainwright analyst Andres Maldonado keeps a Buy rating on CG Oncology (CGON) with a $75 price target after Pfizer (PFE) announced positive ...
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback